Cairo-Mubasher: Nile Pharmaceuticals and Chemical Industries reported a 37% fall in H1-15/16 net earnings to EGP 4.8 million, compared with EGP 7.6 million in the same period a year ago.
The company's revenues increased to EGP 174.6 million from EGP 164.2 million in H1/14/15.
